ESNT Essent Group Ltd.
Essent Group Ltd., through its subsidiaries, provides private mortgage insurance and reinsurance, and title insurance and settlement services to mortgage lenders, borrowers, and investors in the United States. It operates through two segments, Mortgage Insurance and Reinsurance. The company's mortgage insurance products include primary, pool, and master policy. It also provides information technology maintenance and development services; customer support-related services; underwriting consulting services to third-party reinsurers; and contract underwriting services, as well as credit risk management products. In addition, the company offers title insurance and settlement services; and title insurance underwriting services. It serves the originators of residential mortgage loans, such as regulated depository institutions, mortgage banks, credit unions, and other lenders. Essent Group Ltd. was founded in 2008 and is headquartered in Hamilton, Bermuda.…
Industry Peers
Insurance - SpecialtyKey Statistics
About Essent Group (NYSE: ESNT)
›
Essent Group (NYSE: ESNT) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Insurance - Specialty industry, part of the Financial Services sector, and reports about 523 employees.
The shares were at 63.79 USD on 19 November 2026, up 6.0% over 52 weeks. Its 52-week range is 55.34 USD to 71.84 USD: the price is 11.2% below the high and 15.3% above the low.
At a market capitalisation of 5.61B USD, it trades at 8.7 times trailing earnings and 8.1 times forward earnings. The median trailing P/E of its 17 largest Insurance - Specialty peers is 9.2, so ESNT is valued in line with them. It pays a dividend yielding 2.18% (it pays out 19% of its earnings), against a median of 2.84% among the dividend payers in that peer group.
Essent Group reports return on equity of 12.0%, an operating margin of 61.6% and revenue up 20.0% year over year.
It holds more cash than debt, a net cash position of 168.50M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 8 analysts cover the stock, with an average rating of Buy; their mean price target of 70.88 USD is 11.1% above the current price. The next earnings report is expected on 12 February 2027.